Bryn Pharma Raises $11 Million in Financing to Advance Bi-Dose Epinephrine Nasal Spray for Anaphylaxis

Expansion of Fourth Round of Capital to be used to Complete Development of Compact, Innovative, Needle-Free Device for Administration of Emergency Epinephrine

To read the full article, visit Cision PR Newswire.